Investigation to Identify Predictors of Response to a Treatment With Montelukast
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The main aim of the study is to develop a method that allows responders to be distinguished
from non-responders before long-term treatment is initiated. Subsidiary aims are to record
changes in pulmonary functional parameters, NO concentrations and peak flow variability, the
use of beta2 sympathomimetics and the asthma symptom score.